🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

47 results for “Syndax Pharmaceuticals” Clear

  1. Revumenib, Revumenib, SNDX-5613, Revumenib, Revumenib, SNDX-5613

    Syndax Pharmaceuticals

    Relapsed or Refractory Acute Leukemias

    phase 2 small molecule active

    1 trial

  2. SNDX-5613

    Syndax Pharmaceuticals

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  3. SNDX-6352

    Syndax Pharmaceuticals

    Coronavirus

    phase 2 small molecule terminated

    1 trial

  4. Venetoclax

    Syndax Pharmaceuticals

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  5. entinostat

    Syndax Pharmaceuticals

    Breast Cancer

    phase 2 small molecule completed

    4 trials

  6. entinostat

    Syndax Pharmaceuticals

    Estrogen Receptor-negative Breast Cancer

    phase 2 small molecule terminated

    1 trial

  7. entinostat

    Syndax Pharmaceuticals

    Epithelial Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  8. Axatilimab

    Syndax Pharmaceuticals

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  9. Entinostat

    Syndax Pharmaceuticals

    Pancreas Cancer

    phase 1 small molecule terminated

    1 trial

  10. Entinostat

    Syndax Pharmaceuticals

    Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

  11. Entinostat

    Syndax Pharmaceuticals

    Drug Interaction

    phase 1 small molecule completed

    1 trial

  12. Entinostat

    Syndax Pharmaceuticals

    Neoplasms

    phase 1 small molecule completed

    2 trials

  13. Entinostat

    Syndax Pharmaceuticals

    Fallopian Tube Cancer

    phase 1 small molecule terminated

    1 trial

  14. Entinostat

    Syndax Pharmaceuticals

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  15. Entinostat

    Syndax Pharmaceuticals

    Volunteers

    phase 1 small molecule completed

    2 trials

  16. Phase 1 Study of Revumenib in Combination with Intensive Chemotherapy in Participants with AML Harboring Alterations in KMT2A/MLL, NPM1, or NUP98 Genes

    Syndax Pharmaceuticals

    Acute Myeloid Leukemias

    phase 1 other active

    1 trial

  17. Revumenib

    Syndax Pharmaceuticals

    Relapsed/Refractory Leukemias

    phase 1 small molecule completed

    1 trial

  18. Revumenib

    Syndax Pharmaceuticals

    Refractory Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  19. Revumenib

    Syndax Pharmaceuticals

    Blinatumomab

    phase 1 small molecule active

    1 trial

  20. Revumenib

    Syndax Pharmaceuticals

    Acute Leukemia

    phase 1 small molecule completed

    1 trial

  21. SNDX-275

    Syndax Pharmaceuticals

    Breast Cancer

    phase 1 small molecule terminated

    1 trial

  22. SNDX-5613

    Syndax Pharmaceuticals

    Acute Myeloid Leukemias

    phase 1 small molecule active

    1 trial

  23. entinostat

    Syndax Pharmaceuticals

    Lung Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources